[HTML][HTML] Beyond the barriers of light penetration: strategies, perspectives and possibilities for photodynamic therapy

S Mallidi, S Anbil, AL Bulin, G Obaid, M Ichikawa… - Theranostics, 2016 - ncbi.nlm.nih.gov
Photodynamic therapy (PDT) is a photochemistry based treatment modality that involves the
generation of cytotoxic species through the interactions of a photosensitizer molecule with …

[HTML][HTML] Porphyrinoid biohybrid materials as an emerging toolbox for biomedical light management

V Almeida-Marrero, E van de Winckel… - Chemical Society …, 2018 - pubs.rsc.org
The development of photoactive and biocompatible nanomaterials is a current major
challenge of materials science and nanotechnology, as they will contribute to promoting …

Targeting prostate cancer: prostate‐specific membrane antigen based diagnosis and therapy

T Wüstemann, U Haberkorn, J Babich… - Medicinal research …, 2019 - Wiley Online Library
The high incidence rates of prostate cancer (PCa) raise demand for improved therapeutic
strategies. Prostate tumors specifically express the prostate‐specific membrane antigen …

[HTML][HTML] Ligand-targeted delivery of photosensitizers for cancer treatment

P Gierlich, AI Mata, C Donohoe, RMM Brito, MO Senge… - Molecules, 2020 - mdpi.com
Photodynamic therapy (PDT) is a promising cancer treatment which involves a
photosensitizer (PS), light at a specific wavelength for PS activation and oxygen, which …

[HTML][HTML] EGFR targeted nanobody–photosensitizer conjugates for photodynamic therapy in a pre-clinical model of head and neck cancer

PBAA Van Driel, MC Boonstra, MD Slooter… - Journal of Controlled …, 2016 - Elsevier
Photodynamic therapy (PDT) induces cell death through local light activation of a
photosensitizer (PS) and has been used to treat head and neck cancers. Yet, common PS …

[HTML][HTML] Prostate-specific membrane antigen as a target for cancer imaging and therapy

AP Kiess, SR Banerjee, RC Mease… - The quarterly journal …, 2015 - ncbi.nlm.nih.gov
The prostate-specific membrane antigen (PSMA) is a molecular target whose use has
resulted in some of the most productive work toward imaging and treating prostate cancer …

[HTML][HTML] Near infrared photoimmunotherapy: a review of recent progress and their target molecules for cancer therapy

TM Mohiuddin, C Zhang, W Sheng, M Al-Rawe… - International journal of …, 2023 - mdpi.com
Near infrared photoimmunotherapy (NIR-PIT) is a newly developed molecular targeted
cancer treatment, which selectively kills cancer cells or immune-regulatory cells and induces …

[HTML][HTML] Photodynamic therapy: targeting cancer biomarkers for the treatment of cancers

X Wang, D Luo, JP Basilion - Cancers, 2021 - mdpi.com
Simple Summary Photodynamic therapy (PDT) is a minimally invasive treatment option that
can kill cancerous cells by subjecting them to light irradiation at a specific wavelength. The …

Nanobody-targeted photodynamic therapy selectively kills viral GPCR-expressing glioblastoma cells

TWM De Groof, V Mashayekhi, TS Fan… - Molecular …, 2019 - ACS Publications
Photodynamic therapy (PDT) eradicates tumors by the local activation of a photosensitizer
with near-infrared light. One of the aspects hampering the clinical use of PDT is the poor …

Photodynamic therapy for prostate cancer–A narrative review

M Osuchowski, D Bartusik-Aebisher… - Photodiagnosis and …, 2021 - Elsevier
This article is a review of approaches to treatment of low and high-grade prostate cancer
including a discussion of active treatment vs. active surveillance for patients with low-grade …